| Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, MBW Spanier, ... Hepatology 58 (6), 2045-2055, 2013 | 646 | 2013 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 266 | 2018 |
| Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ... Hepatology 59 (5), 1954-1963, 2014 | 190 | 2014 |
| Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data SM Zinkstok, MDI Vergouwen, ST Engelter, PA Lyrer, LH Bonati, M Arnold, ... Stroke 42 (9), 2515-2520, 2011 | 178 | 2011 |
| Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: Disease penetrance and expression in cardiac ryanodine receptor mutation–carrying relatives C van der Werf, I Nederend, N Hofman, N van Geloven, C Ebink, ... Circulation: Arrhythmia and Electrophysiology 5 (4), 748-756, 2012 | 177 | 2012 |
| Oil-based or water-based contrast for hysterosalpingography in infertile women K Dreyer, J Van Rijswijk, V Mijatovic, M Goddijn, HR Verhoeve, ... New England Journal of Medicine 376 (21), 2043-2052, 2017 | 175 | 2017 |
| Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome: a study of electrocardiograms … PG Postema, PFHM van Dessel, JA Kors, AC Linnenbank, G van Herpen, ... Journal of the American College of Cardiology 55 (8), 789-797, 2010 | 175 | 2010 |
| Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a … MAM Beijk, M Klomp, NJW Verouden, N van Geloven, KT Koch, ... European heart journal 31 (9), 1055-1064, 2010 | 146 | 2010 |
| Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment … P Damman, MAM Beijk, WJ Kuijt, NJW Verouden, N van Geloven, ... Journal of the American College of Cardiology 57 (1), 29-36, 2011 | 130 | 2011 |
| The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI … WJ Kikkert, N van Geloven, MH van der Laan, MM Vis, J Baan, KT Koch, ... Journal of the American College of Cardiology 63 (18), 1866-1875, 2014 | 123 | 2014 |
| Neurocognitive deficits in children with sickle cell disease: a comprehensive profile CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ... Pediatric blood & cancer 56 (5), 783-788, 2011 | 121 | 2011 |
| Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi T Israëls, MD van de Wetering, P Hesseling, N van Geloven, HN Caron, ... Pediatric blood & cancer 53 (1), 47-52, 2009 | 118 | 2009 |
| Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis KA Broeze, BC Opmeer, N Van Geloven, S Coppus, JA Collins, ... Human reproduction update 17 (3), 293-300, 2011 | 113 | 2011 |
| Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease B Post, D Muslimovic, N van Geloven, JD Speelman, B Schmand, ... Movement Disorders 26 (3), 449-456, 2011 | 106 | 2011 |
| Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD DC Velseboer, M Broeders, B Post, N van Geloven, JD Speelman, ... Neurology 80 (7), 627-633, 2013 | 103 | 2013 |
| Prediction meets causal inference: the role of treatment in clinical prediction models N van Geloven, SA Swanson, CL Ramspek, K Luijken, M van Diepen, ... European journal of epidemiology 35, 619-630, 2020 | 82 | 2020 |
| Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern? H Thoonsen, E Richard, P Bentham, R Gray, N van Geloven, RJ De Haan, ... Stroke 41 (11), 2690-2692, 2010 | 80 | 2010 |
| Physiological-based cord clamping in very preterm infants—Randomised controlled trial on effectiveness of stabilisation R Knol, E Brouwer, T van den Akker, P DeKoninck, N van Geloven, ... Resuscitation 147, 26-33, 2020 | 72 | 2020 |
| Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial PF van der Meer, PF Ypma, N van Geloven, JA van Hilten, ... Blood, The Journal of the American Society of Hematology 132 (2), 223-231, 2018 | 70 | 2018 |
| Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice–the ECSTATIC study: a cluster randomised non … CH Luymes, RKE Poortvliet, N van Geloven, MWM de Waal, YM Drewes, ... BMC medicine 16, 1-14, 2018 | 66 | 2018 |
